InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,399.22
(
-0.51%
)
US TECH 100
18,362.00
(
-0.93%
)
Dow Jones
39,935.07
(
0.20%
)
Brent Oil
81.69
(
0.18%
)
Bitcoin
67,052.47
(
1.92%
)
Post# of 252685
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

scott2987

Send PM Follow Ignore
Followers 0
Posts 47
Boards Moderated 0
Alias Born 11/04/2003

scott2987

Re: DewDiligence post# 209317

Wednesday, 02/22/2017 1:57:23 PM

Wednesday, February 22, 2017 1:57:23 PM

Post# of 252685
I have been a little surprised that no question came up yesterday or in previous presentation by CFO about whether MNTA was developing their Humira biosimilar to be interchangable and Craig simply referred to it as a high quality biosimilar and interchangable status was never mentioned. Is there a reason they would not talk about that?
Thanks
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up